Vital Biosciences
Work Here?
About
Company Stage
Seed
Employees
51-200
Industries
Biotechnology, Healthcare
Total Funding
$46.7M
Headquarters
N/A
Founded
N/A
Simplify's Take
What believers are saying
- The $48 million funding round indicates strong investor confidence and provides Vital Biosciences with the resources to innovate and potentially revolutionize the blood diagnostic industry.
- Vital Biosciences' focus on accessible diagnostics could lead to widespread adoption and significant impact in healthcare, improving clinical interventions.
What critics are saying
- The shadow of Theranos looms large, and Vital Biosciences must overcome skepticism and prove the reliability and accuracy of its technology.
- The competitive landscape in blood diagnostics is intense, with numerous startups vying for market share, which could challenge Vital Biosciences' growth and sustainability.
What makes Vital Biosciences unique
- Vital Biosciences is positioning itself as a leader in the new wave of blood diagnostic startups, focusing on accessibility and reliability in the wake of Theranos' failure.
- The backing from high-profile investors like Sam Altman and Marc Benioff provides Vital Biosciences with significant credibility and financial support, setting it apart from other emerging companies in the field.
Help us improve and share your feedback! Did you find this helpful?
Growth & Insights
Headcount
6 month growth
↑ 36%1 year growth
↑ 36%2 year growth
↑ 45%Vital Biosciences is Hiring for 0 Jobs on Simplify!
Find jobs on Simplify and start your career today
💡
We update Vital Biosciences's jobs every 8 hours, so check again soon! Browse all jobs →